Last reviewed · How we verify

NCT05096377

Hemi-diaphragmatic Paresis and Erector Spinae Plane Block

Completed Last updated 15 February 2022
What this trial tests

trial testing ESP block in Anesthesia, Regional in 20 participants. Completed in 31 January 2022.

Timeline
7 October 2021
Primary endpoint
31 January 2022
31 January 2022

Quick facts

Lead sponsorAntalya Training and Research Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment20
Start date7 October 2021
Primary completion31 January 2022
Estimated completion31 January 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Antalya Training and Research Hospital

Who can join

Adults 18 to 85, any sex, with Anesthesia, Regional or Shoulder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To assess the incidence of hemi-diaphragmatic paresis following ultrasound-guided erector spinae plane (ESP) block

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of ESP block

Trials testing the same drug.

Other recruiting trials for Anesthesia, Regional

Currently open trials in the same condition.

Other Antalya Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05096377.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing